Rabishield 100 Injection is used to treat individuals following suspected exposure to the rabies virus, such as from an animal bite or scratch. This prescription biological formulation provides critical post-exposure prophylaxis to prevent severe viral progression. It serves as a vital first-line defense to protect the central nervous system.
It contains Rabies Human Monoclonal Antibody as its active ingredient, which functions as a potent immunizing agent. This medication works by immediately binding to and neutralising the virus directly at the site of exposure. This targeted mechanical action prevents the pathogen from migrating to nerve pathways.
The injection provides the immediate passive immunity required until the rabies vaccine can trigger the body's active immune response. This specialised formulation must be administered by a healthcare professional as soon as possible after exposure. Consult your healthcare provider immediately following any suspected animal contact for appropriate treatment.

































